Properties of arsenic sulphide (β-As4S4) modified by mechanical activation
Source abstract
Abstract
Arsenic sulphide β-As4S4 has been modified by mechanical activation in a planetary ball mill. As a consequence, the solid-state properties and dissolution yield have been influenced. The following changes were observed: the increase of specific surface area, changes in the morphology (the formation of submicron particles), the occurrence of nanoparticles (21–31 nm), changes in crystal lattice parameters and changes in the Raman shift of particular vibrations. As a consequence of these changes, the dissolution rate of β-As4S4 has been increased, which is a challenge for the application in cancer research.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Phase-change materials and chalcogenides · Selenium in Biological Systems · Crystal Structures and Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Bonazzi P, Bindi L (2008) A crystallographic review of arsenic sulfides: effects of chemical variations and changes induced by exposure to light. Z Kristallogr 223:132–14710.1524/zkri.2008.0011 ↗
2. Popescu M (2005) Disordered chalcogenide optoelectronic materials: phenomena and applications. J Optoelectron Adv Mater 7:2189–2210
3. Adam JL, Zhang X (2014) Chalcogenide glasses: preparation, properties and applications chalcogenide glasses: preparation properties and applications, vol 44. Woodhead Publishing, Oxford
4. Cui S, Chahal R, Shpotyuk Y, Boussard C, Lucas J, Charpentier F, Tariel H, Loreal O, Nazabal V, Sire O, Monbet V, Yang ZY, Lucas P, Bureau B (2014) Selenide and telluride glasses for mid-infrared bio-sensing. Proc SPIE 893805:1–9
5. Shpotyuk Y, Boussard-Pledel C, Nazabal V, Chahal R, Ari J, Pavlyk B, Cebulski J, Doualan JL, Bureau B (2015) Ga-modified As2Se3–Te glasses for active applications in IR photonics. Opt Mater 46:228–23210.1016/j.optmat.2015.04.024 ↗
6. Liu J, Lu YF, Wu Q, Goyer RA, Waalkes MP (2008) Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite. J Pharmacol Exp Ther 326:363–36810.1124/jpet.108.139543 ↗
7. Dilda PJ, Hogg PJ (2007) Arsenical-based cancer drugs. Cancer Treat Rev 33:542–56410.1016/j.ctrv.2007.05.001 ↗
8. Baláž P (2008) Mechanochemistry in nanoscience and minerals engineering. Springer, Berlin Heidelberg
9. Baláž P, Achimovičová M, Baláž M, Billik P, Cherkezova-Zheleva Z, Criado JM, Delogu F, Dutková E, Gaffet E, Gotor FJ, Kumar R, Mitov I, Rojac T, Senna M, Streletskii A, Wieczorek-Ciurowa K (2013) Hallmarks of mechanochemistry: from nanoparticles to technology. Chem Soc Rev 42:7571–763710.1039/c3cs35468g ↗
10. Baláž P, Choi WS, Dutková E (2007) Mechanochemical modification of properties and reactivity of nanosized arsenic sulphide As4S4. J Phys Chem Solids 68:1178–118310.1016/j.jpcs.2007.01.008 ↗
11. Tuktabiev MA, Popova SV, Brazhkin VV, Lyapin AG, Katayama Y (2009) Compressibility and polymorphism of alpha-As4S4 realgar under high pressure. J Phys-Condens Matter 21:38540110.1088/0953-8984/21/38/385401 ↗
12. Brazhkin VV, Bolotina NB, Dyuzheva TI, Gavriliuk AG, Lyapin AG, Popova SV, Samulski S (2011) AsS layered-structure compound: new kind of covalent crystals. CrystEngComm 13:2599–260310.1039/c0ce00861c ↗
13. Hejny C, Sagl R, Tobbens DM, Miletich R, Wildner M, Nasdala L, Ullrich A, Balic-Zunic T (2012) Crystal-structure properties and the molecular nature of hydrostatically compressed realgar. Phys Chem Miner 39:399–41210.1007/s00269-012-0495-y ↗
14. Lepore GO, Ballaran TB, Nestola F, Bindi L, Pasqual D, Bonazzi P (2012) Compressibility of beta-As4S4: an in situ high-pressure single-crystal X-ray study. Mineral Mag 76:963–97310.1180/minmag.2012.076.4.12 ↗
15. Wu JZ, Ho PC (2006) Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur J Pharm Sci 29:35–4410.1016/j.ejps.2006.05.002 ↗
16. Baláž P, Fabián M, Pastorek M, Cholujová D, Sedlák J (2009) Mechanochemical preparation and anticancer effect of realgar As4S4 nanoparticles. Mater Lett 63:1542–154410.1016/j.matlet.2009.04.008 ↗
17. Baláž P, Bujňáková Z, Kartachova O, Fabián M, Stalder B (2013) Properties and bioaccessibility of arsenic sulphide nanosuspensions. Mater Lett 104:84–8610.1016/j.matlet.2013.04.003 ↗
18. Baláž P, Nguyen AV, Fabián M, Cholujová D, Pastorek M, Sedlák J, Bujňáková Z (2011) Properties of arsenic sulphide As4S4 nanoparticles prepared by high-energy milling. Powder Technol 211:232–23610.1016/j.powtec.2011.04.027 ↗
19. Zhao WZ, Lu X, Yuan Y, Liu CS, Yang BC, Hong H, Wang GY, Zeng FY (2011) Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines. Int J Nanomed 6:1569–157710.2147/IJN.S21373 ↗
20. Baláž P, Sedlák J, Pastorek M, Cholujová D, Vignarooban K, Bhosle S, Boolchand P, Bujňáková Z, Dutková E, Kartachova O, Stalder B (2012) Arsenic sulphide As4S4 nanoparticles: physico-chemical properties and anticancer effects. J Nano Res 18–19:149–15510.4028/www.scientific.net/JNanoR.18-19.149 ↗
21. Tian Y, Wang XB, Xi RG, Pan WS, Jiang S, Li Z, Zhao Y, Gao GH, Liu D (2014) Enhanced antitumor activity of realgar mediated by milling it to nanosize. Int J Nanomed 9:745–757
22. Shi F, Feng NP, Omari-Siaw E (2015) Realgar nanoparticle-based microcapsules: preparation and in vitro/in vivo characterizations. J Pharm Pharmacol 67:35–4210.1111/jphp.12314 ↗
23. James SL, Adams CJ, Bolm C, Braga D, Collier P, Friščić T, Grepioni F, Harris KDM, Hyett G, Jones W, Krebs A, Mack J, Maini L, Orpen AG, Parkin IP, Shearouse WC, Steed JW, Waddell DC (2012) Mechanochemistry: opportunities for new and cleaner synthesis. Chem Soc Rev 41:413–44710.1039/C1CS15171A ↗
24. WinXPOW Stoe (2010) Powder diffraction software package. Stoe&Cie GmbH, Darmstadt
25. Kraus W, Nolze G (1996) POWDER CELL—A program for the representation and manipulation of crystal structures and calculation of the resulting X-ray powder patterns. J Appl Crystallogr 29:301–30310.1107/S0021889895014920 ↗
26. Rodriguez-Carvajal J (2001) Recent developments of the program FullProf. Comission on powder diffraction (IUCr), vol Newsletter 26
27. Hill RJ, Howard CJ (1987) Quantitative phase-analysis from neutron powder diffraction data using the Rietveld method. J Appl Crystallogr 20:467–47410.1107/S0021889887086199 ↗
28. Rodriguez-Carvajal J, Roisnel T (2004) Line broadening analysis using FullProf*: determination of microstructural properties. European Powder Diffr Epdic 8(443–4):123–126
29. Horter D, Dressman JB (2001) Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Del Rev 46:75–8710.1016/S0169-409X(00)00130-7 ↗
30. Opoczky L (1977) Fine grinding and agglomeration of silicates. Powder Technol 17:1–710.1016/0032-5910(77)85037-7 ↗
31. Juhasz AZ (1990) Mechanical activation of minerals by grinding: pulverizing and morphology of particles. Ellis Horwood, Chichester
32. Rhodes M (1998) Introduction to particle technology. Wiley, Chichester
33. Zoppi M, Pratesi G (2012) The dual behavior of the beta-As4S4 altered by light. Am Mineral 97:890–89610.2138/am.2012.3968 ↗
34. Baláž P, Baláž M, Achimovičová M, Bujňáková Z, Dutková E (2014) Mechanochemistry of solids: new prospects for extractive metallurgy, materials science and medicine. Acta Phys Pol, A 126:879–88310.12693/APhysPolA.126.879 ↗
35. Muniz-Miranda M, Sbrana G, Bonazzi P, Menchetti S, Pratesi G (1996) Spectroscopic investigation and normal mode analysis of As4S4 polymorphs. Spectrochim Acta Part a-Mol Biomol Spectrosc 52:1391–140110.1016/0584-8539(96)01698-4 ↗
36. Forneris R (1969) The infrared and Raman spectra of realgar and orpiment. Am Miner 54:1062–1074
37. Soong R, Farmer VC (1978) The identification of sulphide minerals by infrared spectroscopy. Mineral Mag 42:27710.1180/minmag.1978.042.322.17 ↗
38. Wagner T, Kasap SO, Vlcek M, Sklenar A, Stronski A (1998) Modulated-temperature differential scanning calorimetry and Raman spectroscopy studies of AsxSi100-x glasses. J Mater Sci 33:5581–558810.1023/A:1004455929749 ↗
39. Bonazzi P, Menchetti S, Pratesi G, Muniz-Miranda M, Sbrana G (1996) Light-induced variations in realgar and beta-As4S4: X-ray diffraction and Raman studies. Am Miner 81:874–88010.2138/am-1996-7-810 ↗
40. Trentelman K, Stodulski L, Pavlosky M (1996) Characterization of pararealgar and other light-induced transformation products from realgar by Raman microspectroscopy. Anal Chem 68:1755–176110.1021/ac951097o ↗
41. Georgiev DG, Boolchand P, Jackson KA (2003) Intrinsic nanoscale phase separation of bulk As2S3 glass. Phil Mag 83:2941–295310.1080/1478643031000151196 ↗
42. Chen P, Holbrook C, Boolchand P, Georgiev DG, Jackson KA, Micoulaut M (2008) Intermediate phase, network demixing, boson and floppy modes, and compositional trends in glass transition temperatures of binary AsxS1-x system. Phys Rev B 78:22420810.1103/PhysRevB.78.224208 ↗
43. Burmeister CF, Kwade A (2013) Process engineering with planetary ball mills. Chem Soc Rev 42:7660–766710.1039/c3cs35455e ↗
44. Boldyrev VV (1987) Mechanochemistry of inorganic solids. Thermochim Acta 110:303–31710.1016/0040-6031(87)88239-4 ↗
45. Amidon GL, Lennernas H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification—the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–42010.1023/A:1016212804288 ↗
46. Peltonen L, Hirvonen J (2010) Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol 62:1569–157910.1111/j.2042-7158.2010.01022.x ↗
47. Merisko-Liversidge E, Liversidge GG (2011) Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Del Rev 63:427–44010.1016/j.addr.2010.12.007 ↗
48. Parrot EL (1990) Comminution. In: Swarbrick J, Boylan JC (eds) Encyclopedia of Pharmaceutical Technology, vol 3. Marcel Dekker, New York, pp 101–121
49. Descamps M, Willart JF (2016) Perspectives on the amorphisation/milling relationship in pharmaceutical materials. Adv Drug Del Rev 100:51–6610.1016/j.addr.2016.01.011 ↗
50. Kesisoglou F, Panmai S, Wu YH (2007) Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Del Rev 59:631–64410.1016/j.addr.2007.05.003 ↗
51. Baláž P, Sedlák J (2010) Arsenic in cancer treatment: challenges for application of realgar nanoparticles (A minireview). Toxins 2:1568–158110.3390/toxins2061568 ↗
52. Bujňáková Z, Baláž P, Makreski P, Jovanovski G, Čaplovičová M, Čaplovič Ľ, Shpotyuk O, Ingram A, Lee TC, Cheng JJ, Sedlák J, Turianicová E, Zorkovská A (2015) Arsenic sulfide nanoparticles prepared by milling: properties, free-volume characterization, and anti-cancer effects. J Mater Sci 50:1973–198510.1007/s10853-014-8763-5 ↗